You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 28 No. 2, February 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (180)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Necrotizing Encephalopath Following Intraventricular Instillatio of Methotrexate

William R. Shapiro, MD; Norman L. Chernik, M

Arch Neurol. 1973;28(2):96-102.


Abstract

Three children with posterior fossa tumors and evidence of ventricular obstruction were treated by instillation into the lateral cerebral ventricle of methotrexate in total doses ranging from 86 to 190 mg given over 3 to 13 months. All three patients developed neurological signs of bilateral cerebral or upper brainstem dysfunction. In two, unusual lesions consisting of areas of coagulation necrosis with fibrinoid degeneration and thrombosis of blood vessels and reactive astrocytosis involved the periventricular white matter. The third patient died a year later; his brain showed periventricular necrosis without blood vessel changes. Other patients without ventricular obstruction were treated with comparable intraventricular doses of methotrexate without incident. The most likely cause of the necrotizing encephalopathy was absorption of toxic doses of methotrexate through the lateral ventricular wall in patients with ventricular obstruction.



Author Affiliations

From the Neuropsychiatric Service, Memorial Hospital for Cancer and Allied Diseases and the Department of Neurology, Cornell University Medical College, New York.


Footnotes

Accepted for publication Aug 17, 1972.

Reprint requests to 444 E 68th St, New York 10021 (Dr. Shapiro).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma
Linnebank et al.
Neuro Oncol Duke 2009;11:2-8.
ABSTRACT | FULL TEXT  

Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy
Dietrich et al.
The Oncologist 2008;13:1285-1295.
ABSTRACT | FULL TEXT  

Meningeal Carcinomatosis
Theodore and Gendelman
Arch Neurol 1981;38:696-699.
ABSTRACT  

Brain Tumor: Current Status of Treatment and Its Complications
Arch Neurol 1975;32:781-784.
ABSTRACT  

Pontine Glioma: High-Dose Methotrexate and Leucovorin Rescue
Rosen et al.
JAMA 1974;230:1149-1152.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.